Biologically speaking, there is no organ as vital or complex as the brain. While there have been ... to treating diseases like Alzheimer's and Parkinsons, something Dr. Kellyann Niotis, a ...
The idea that endogenous progenitor cells might be harnessed to replace neurons lost in neurodegenerative diseases is popular, but requires the development of methods to stimulate their ...
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...
Jan. 3, 2025 — Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug ... 'Dancing the Blues Away' Seen in Brain ...
ABL Bio’s first-in-class bispecific antibodies for Parkinson’s disease combine unprecedented blood–brain barrier penetration with a robust mechanism of action for improved therapeutic efficacy.
Delray Medical Center cut the ribbon on its newest high-tech machine last week that targets brain areas to treat movement disorders such as essential tremor and tremor-dominant Parkinson’s disease.